Axes 1–2
Traceability and studiedness
Scored from the available data. Identity: Only the species or an unresolved identity is available. Quantity disclosure: 0.0%. Potency: Potency is stated through expiry.
product · release 2026-09-20
VitaCeutical Labs Acidophilus & Bifidus
Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.
Organisms, fibers and substances on this label
Printed organisms · observed
Organism list
Quantities reflect printed organism rows.
| Printed name and notes | Normalized organism | Printed code | Printed deposit | Printed quantity | Flags |
|---|---|---|---|---|---|
| Lactobacillus acidophilus | Lactobacillus acidophilus | not printed | not printed | not printed | T4; observed; quantity unavailable |
| Bifidobacterium infantis | Bifidobacterium infantis | not printed | not printed | not printed | T4; observed; quantity unavailable |
Pack, dose and cost
What the label says beyond the organisms
- Pack
- 100 Capsule(s) · Capsule
- Serving
- 1 Capsule(s) · 3 serving(s) a day
- Days of supply
- 33.3
- Potency per day
- undefined: no numeric quantity printed
- Cost per day
- no observed price in this release
- Printed claims
- 2 on the label (All Other, Structure/Function). A printed claim is not evidence and does not enter any axis.
- Other ingredients
- 6 printed: Capsule, Cellulose, Maltodextrin, Dextrose, Magnesium Stearate, Silica
- Label target groups
- Adult (18 - 50 Years), Gluten Free, Dairy Free
- Suggested use
- Suggested Use: Take one capsule up to three times daily, preferably before meals with a glass of water.
- UPC
- 7 19985 71640 9
Printed potency
Quantity on the label
No numeric quantity is printed on 2 organism rows of the latest observed label; potency basis Potency is stated through expiry. 2 rows sit inside a proprietary blend, so their individual amounts are not disclosed.
Evidence behind the label
Located human trials per organism
| Organism on this label | PubMed records indexed as human randomized controlled trials |
|---|---|
| Bifidobacterium infantis | 58 |
| Lactobacillus acidophilus | 381 |
Counts describe records matching each organism's published query, including trials of multi-ingredient products; they are not a count of trials of this product.
Context
Where this score sits
This formulation scores above 76.6% of the 4,101 scored formulations in this release. The score is a preference-dependent summary of the axes, not a health claim.
A140.00
A2100.00
GIS73.00
Axes 3–4
Measurement and brand panel
Not a measurement product, so this axis does not apply.
No brand review panel is published in this release.
Price column
Observed price
undefined: no permitted price observation in this release
Sensitivity
Preference-dependent summary
Preference interval 54.00–76.30; rank uncertainty 1094.00–1698.05; rank class 2.
Versions
Typed label snapshot edges
No typed edge in this release.
Preference tool
Weights slider
The readout recomputes the arithmetic summary from the published component JSON. Axis fields remain primary.
Brand: VitaCeutical Labs — every published product of this brand, its potency basis and its observed reformulations.
Elsewhere in this release
Related pages
Findings computed over the whole corpus: Potency basis census · Strain dose match · Supplier code network
Tools: Unit value calculator · DSLD product check
Citation
Cite this page
Ivitskiy, I. (2026). VitaCeutical Labs Acidophilus & Bifidus. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/p/acidophilus-bifidus-53748/
The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.
Citable atoms
Release claims
VitaCeutical Labs Acidophilus & Bifidus: 0 of 2 observed organisms name a strain, and 0 print a deposit identifier. Latest observed label 53748. Window: NIH DSLD snapshot Sep 2026.
0 / 2 observed organisms · NIH DSLD snapshot Sep 2026 · product.organisms · checked 2026-09-20T00:00:00Z · snapshot b7633f732437VitaCeutical Labs Acidophilus & Bifidus: 1 of 1 observed label snapshots state a potency basis; latest basis is through expiry. Quantities reflect printed organism rows. Window: NIH DSLD snapshot Sep 2026.
1 / 1 observed label snapshots · NIH DSLD snapshot Sep 2026 · product.potency · checked 2026-09-20T00:00:00Z · snapshot b7633f732437VitaCeutical Labs Acidophilus & Bifidus: 1 of 1 selected label snapshots have a numeric Gut Index Score; GIS 73.00 on the 100-point scale; rank class 2 of 4 across 3,279 scored formulations; nominal weights varied from 80.0% to 120.0% in preference sensitivity. Window: NIH DSLD snapshot Sep 2026.
1 / 1 selected label snapshots · NIH DSLD snapshot Sep 2026 · product.gis · checked 2026-09-20T00:00:00Z · snapshot b7633f732437VitaCeutical Labs Acidophilus & Bifidus has 1 observed versions across 1 formulation groups; last recorded edge type: no typed edge. Window: NIH DSLD snapshot Sep 2026.
1 / 1 formulation groups · NIH DSLD snapshot Sep 2026 · product.versions · checked 2026-09-20T00:00:00Z · snapshot b7633f732437VitaCeutical Labs Acidophilus & Bifidus: 0 of 1 observed versions have numeric prices; latest price No numeric price observation is available in this release.. Window: NIH DSLD snapshot Sep 2026.
0 / 1 observed label versions · NIH DSLD snapshot Sep 2026 · product.price · checked 2026-09-20T00:00:00Z · snapshot b7633f732437